Compile Data Set for Download or QSAR
Report error Found 29 Enz. Inhib. hit(s) with all data for entry = 7332
TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189812BDBM189812(US9174997, 10)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189814BDBM189814(US9174997, 14)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189813BDBM189813(US9174997, 12)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189820BDBM189820(US9174997, 33)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189819BDBM189819(US9174997, 32)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189822BDBM189822(US9174997, 41)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189821BDBM189821(US9174997, 36)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189815BDBM189815(US9174997, 18)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189818BDBM189818(US9174997, 27)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189860BDBM189860(US9174997, 80)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189871BDBM189871(US9174997, 91)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189865BDBM189865(US9174997, 85)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189823BDBM189823(US9174997, 43 (Diastereomer 1))
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189835BDBM189835(US9174997, 55)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189831BDBM189831(US9174997, 51)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189908BDBM189908(US9174997, 128)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189924BDBM189924(US9174997, 144)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189921BDBM189921(US9174997, 141)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189883BDBM189883(US9174997, 103)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189876BDBM189876(US9174997, 96)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189900BDBM189900(US9174997, 120)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189896BDBM189896(US9174997, 116)
Affinity DataIC50: 0.300nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189817BDBM189817(US9174997, 22)
Affinity DataIC50: 0.450nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189811BDBM189811(US9174997, 6)
Affinity DataIC50: 0.5nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189849BDBM189849(US9174997, 69)
Affinity DataIC50: 0.900nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189912BDBM189912(US9174997, 132)
Affinity DataIC50: 1.10nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189830BDBM189830(US9174997, 50)
Affinity DataIC50: 1.60nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189816BDBM189816(US9174997, 20)
Affinity DataIC50: 1.90nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent

TargetNeutrophil elastase(Human)
Bayer Intellectual Property

US Patent
LigandChemical structure of BindingDB Monomer ID 189810BDBM189810(US9174997, 2)
Affinity DataIC50: 10nMpH: 7.4 T: 2°CAssay Description:The potency of the compounds of the invention is ascertained in an in vitro inhibition assay. The HNE-mediated amidolytic cleavage of a suitable pept...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/8/2016
Entry Details
US Patent